Neumora Therapeutics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Neumora Therapeutics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2836 — Biological Products, (No Diagnostic Substances)
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Watertown
- Headquarters state / province
- Massachusetts
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- NMRA
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001885522
- EIN
- 84-4367680
Board of directors
-
Alaa Halawa · DirectorSince 2023
-
David Piacquad · DirectorSince 2023
-
Henry O. Gosebruch · Director · President & CEOSince 2023
-
Joshua Pinto · Director · President & CEOSince 2026
- Since 2023
-
Matthew K. Fust · DirectorSince 2023
-
Maykin Ho · DirectorSince 2023
-
Paul L. Berns · Director · See RemarksSince 2023
Chief executives
Joshua Pinto
· President & CEO
Dates unknown
Henry O. Gosebruch
· President & CEO
Since September 2023
Director election results
Annual meeting of May 27, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
94.4%
-
95.4%
-
95.6%
Board connections
5 of this board's directors also sit on 12 other boards.
- via Kristina Burow and Paul L. Berns
- via Henry O. Gosebruch
- via Maykin Ho
- via Matthew K. Fust
- via Kristina Burow
- via Maykin Ho
- via Kristina Burow
- via Matthew K. Fust
- via Kristina Burow
- via Maykin Ho
- via Kristina Burow
- via Matthew K. Fust
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $14,999,931
- 3 purchases by 3 insiders
- Sold, last 12 months
- $1,091,707
- 16 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +20,553 | $0.72 | $14,798 |
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −20,553 | $1.59 | $32,780 |
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +21,055 | $0.72 | $15,160 |
| Aug 21, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −21,055 | $1.60 | $33,600 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +67,741 | $0.72 | $48,774 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −67,741 | $1.51 | $102,587 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +21,685 | $0.72 | $15,613 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +45,026 | $0.72 | $32,419 |
| Aug 20, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −66,711 | $1.51 | $101,000 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +13,268 | $0.72 | $9,553 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +17,732 | $0.72 | $12,767 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −31,000 | $1.65 | $51,029 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +30,918 | $0.72 | $22,261 |
| Aug 19, 2026 | Aurora Daljit Singh Officer (See Remarks) | Open-market sale | −30,918 | $1.65 | $50,888 |
| Aug 18, 2026 | Aurora Daljit Singh Officer (See Remarks) | Option exercise | +34,162 | $0.72 | $24,597 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.